Ideas and methods on efficient screening of traditional medicines for anti-osteoporosis activity based on M-Act/Tox integrated evaluation using zebrafish.
10.19540/j.cnki.cjcmm.20170928.004
- Author:
Mo WANG
1
;
Jie LING
2
;
Ying CHEN
2
;
Jie SONG
2
;
E SUN
2
;
Zi-Qi SHI
2
;
Liang FENG
2
;
Xiao-Bin JIA
2
;
Ying-Jie WEI
2
Author Information
1. PLA 93318 Army Hospital, Kaiyuan 112300, China.
2. The Third Clinical School of Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, China.
- Publication Type:Journal Article
- Keywords:
activity screening;
effectiveness;
metabolism;
osteoporosis;
safety;
zebrafish
- From:
China Journal of Chinese Materia Medica
2017;42(21):4246-4250
- CountryChina
- Language:Chinese
-
Abstract:
The increasingly apparent liver injury problems of bone strengthening Chinese medicines have brought challenges for clinical application, and it is necessary to consider both effectiveness and safety in screening anti-osteoporosis Chinese medicines. Metabolic transformation is closely related to drug efficacy and toxicity, so it is significant to comprehensively consider metabolism-action/toxicity(M-Act/Tox) for screening anti-osteoporosis Chinese medicines. The current evaluation models and the number of compounds(including metabolites) severely restrict efficient screening in vivo. By referring to previous relevant research and domestic and abroad literature, zebrafish M-Act/Tox integrative method was put forward for efficiently screening anti-osteoporosis herb medicines, which has organically integrated zebrafish metabolism model, osteoporosis model and toxicity evaluation method. This method can break through the bottleneck and blind spots that trace compositions can't achieve efficient and integrated in vivo evaluation, and realize both efficient and comprehensive screening on anti-osteoporosis traditional medicines based on in vivo process taking both safety and effectiveness into account, which is significant to accelerate discovery of effective and safe innovative traditional Chinese medicines for osteoporosis.
